Anagram
PrivateLast Round
Series A
Feb 26, 2025
Total Funding Raised
$31.18M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Anagram is a financial software company that provides a unified revenue cycle management SaaS platform that automates vision insurance billing and claims management for eye care providers.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Vertical SaaS, InsurTech
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anagram Comparables
Compare Anagram with similar companies based on industry and business-model similarity.
Anagram Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 26, 2025 | ||||
| Series A | Mar 4, 2020 | ||||
| Seed | Aug 15, 2019 | ||||
| Seed | Sep 1, 2018 |
Anagram Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Launchpad Digital Health | Seed, Series A |
| General Catalyst | Series A |
| Madrona Venture Group | Series A |
| ManchesterStory Group | Series A |
| Secure Octane | Series A |
| Rogue Venture Partners | Seed, Series A |
| Bloomberg Beta | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 13, 2026
Processes hundreds of millions of dollars in eye care billing annually.
- Mar 13, 2026
Over 2,000 eye care professionals now use the platform.
Anagram Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Anagram's valuation, stock price, and market status.